Belite Bio chief medical officer Hendrik Peter Scholl reports sale of $331,976.10 in common shares
BLTE•Belite Bio Chief Medical Officer Hendrik Peter Scholl sold 2,000 American depositary shares on Nov. 12, 2026, for a total of $331,976.10. His indirect beneficial ownership through Bioptima fell to 12,500 shares.
1. Share sale
Scholl sold four blocks of 500 American depositary shares at prices of $162.0394, $164.6839, $166.8195 and $170.4094 per share. His indirect beneficial ownership through Bioptima fell to 12,500 American depositary shares.




